Related references
Note: Only part of the references are listed.High rates of pulmonary artery occlusions in COVID-19. A meta-analysis
Simone Birocchi et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2021)
Squeezing through the microcirculation: survival adaptations of circulating tumour cells to seed metastasis
Julia Perea Paizal et al.
BRITISH JOURNAL OF CANCER (2021)
Breakthrough venous thromboembolic events in five patients with COVID-19 on direct oral anticoagulants
Paul Lewis et al.
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS (2021)
D-Dimers Level as a Possible Marker of Extravascular Fibrinolysis in COVID-19 Patients
Antonin Trimaille et al.
JOURNAL OF CLINICAL MEDICINE (2021)
Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia
Ning Tang et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Chaolin Huang et al.
LANCET (2020)
Pulmonary Embolism in Patients With COVID-19 Awareness of an Increased Prevalence
Julien Poissy et al.
CIRCULATION (2020)
Reporting of D-dimer data in COVID-19: some confusion and potential for misinformation
Emmanuel J. Favaloro et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2020)
Coagulopathy of Coronavirus Disease 2019
Toshiaki Iba et al.
CRITICAL CARE MEDICINE (2020)
High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study
Julie Helms et al.
INTENSIVE CARE MEDICINE (2020)
SARS-2 Coronavirus-Associated Hemostatic Lung Abnormality in COVID-19: Is It Pulmonary Thrombosis or Pulmonary Embolism?
Jecko Thachil et al.
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2020)
D-dimer is Associated with Severity of Coronavirus Disease 2019: A Pooled Analysis
Giuseppe Lippi et al.
THROMBOSIS AND HAEMOSTASIS (2020)
Pulmonary Embolism or Pulmonary Thrombosis in COVID-19? Is the Recommendation to Use High-Dose Heparin for Thromboprophylaxis Justified?
Marco Cattaneo et al.
THROMBOSIS AND HAEMOSTASIS (2020)
D-dimer levels on admission to predict in-hospital mortality in patients with Covid-19
Litao Zhang et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)
Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy
Ning Tang et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)
All those D-dimers in COVID-19
Jecko Thachil
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)
Heparin resistance in COVID-19 patients in the intensive care unit
D. White et al.
JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2020)
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
Fei Zhou et al.
LANCET (2020)
Dose-adjusted enoxaparin thromboprophylaxis in hospitalized cancer patients: a randomized, double-blinded multicenter phase 2 trial
Jeffrey Zwicker et al.
BLOOD ADVANCES (2020)
The need for accurate D-dimer reporting in COVID-19: Communication from the ISTH SSC on fibrinolysis
Jecko Thachil et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)
ISTH DIC subcommittee communication on anticoagulation in COVID-19
Jecko Thachil et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)
Fibrinolysis and COVID-19: A plasmin paradox
Robert L. Medcalf et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)
Pulmonary post-mortem findings in a series of COVID-19 cases from northern Italy: a two-centre descriptive study
Luca Carsana et al.
LANCET INFECTIOUS DISEASES (2020)
A systematic review of pathological findings in COVID-19: a pathophysiological timeline and possible mechanisms of disease progression
Samuel B. Polak et al.
MODERN PATHOLOGY (2020)
Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Milan, Italy
Corrado Lodigiani et al.
THROMBOSIS RESEARCH (2020)
The Anticoagulant and Nonanticoagulant Properties of Heparin
Danielle M. H. Beurskens et al.
THROMBOSIS AND HAEMOSTASIS (2020)
A Retrospective Review of the Appropriateness of D-Dimer Ordering and Interpretation Using Wells' Clinical Probability Criteria
Monika Oliver et al.
BLOOD (2020)
Dosing of thromboprophylaxis and mortality in critically ill COVID-19 patients
Sandra Jonmarker et al.
CRITICAL CARE (2020)
Patients with isolated pulmonary embolism in comparison to those with deep venous thrombosis. Differences in characteristics and clinical evolution
Gualtiero Palareti et al.
EUROPEAN JOURNAL OF INTERNAL MEDICINE (2019)
Risk of Arterial Thromboembolism in Patients With Cancer
Babak B. Navi et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2017)
Acute Respiratory Distress Syndrome
B. Taylor Thompson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Non-respiratory functions of the lung
Deepak Joseph et al.
BJA EDUCATION (2013)
Pulmonary Embolism Without Deep Venous Thrombosis
Tim Schwartz et al.
ANNALS OF VASCULAR SURGERY (2012)
Contribution of platelets to tumour metastasis
Laurie J. Gay et al.
NATURE REVIEWS CANCER (2011)
Nonthrombotic pulmonary embolism
P. G. Jorens et al.
EUROPEAN RESPIRATORY JOURNAL (2009)
Dose escalation of low molecular weight heparin to manage recurrent venous thromboembolic events despite systemic anticoagulation in cancer patients
M. Carrier et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2009)
Anti-cancer properties of low-molecular-weight heparin: Preclinical evidence
Shaker A. Mousa et al.
THROMBOSIS AND HAEMOSTASIS (2009)
Extravascular fibrin, plasminogen activator, plasminogen activator inhibitors, and airway hyperresponsiveness
SS Wagers et al.
JOURNAL OF CLINICAL INVESTIGATION (2004)
Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer
AYY Lee et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Extravascular coagulation and the plasminogen activator/plasmin system in rheumatoid arthritis
N Busso et al.
ARTHRITIS AND RHEUMATISM (2002)
Share Paper
